期刊文献+

人血管内皮细胞生长因子165重组腺病毒的构建及其在真核细胞中的表达

Construction of hVEGF165 Recombinant Adenovirus Vector and Its Expression in HEK293 Cells
原文传递
导出
摘要 目的:体外构建人血管内皮生长因子165(hVEGF165)的腺病毒表达载体,并检测其在HEK293细胞中的表达。方法:从重组质粒pcDNA3/hVEGF165中获得hVEGF165,经酶切及测序鉴定,将hVEGF165基因亚克隆到穿梭质粒pAdTrack-CMV,重组穿梭质粒经酶切线性化后,与pAEdasyl质粒在大肠杆菌BSJ183中进行同源重组,线性化后转染HEK293细胞进行包装扩增获取重组病毒上清,同时应用RT-PCR及ELISA法检测hVEGF165的表达。结果:目的基因的测序结果与人VEGF165序列(Genbank)相符。转染后经RT-PCR和ELISA检测证实转染重组质粒组hVEGF165 mRNA及蛋白表达,而转染空质粒组及未转染组没有检测到hVEGF165的表达。结论:本研究构建了人VEGF165重组腺病毒表达载体pAd-hVEGF165,并能成功地在HEK293细胞中表达。 Objective: To construct human vascular endothelial growth factor165(hVEGF165) recombinant adenovirus and investigate its expression in HEK293.Methods: The target gene of human VEGF165 was obtained from plasmid pcDNA3/hVEGF165 and was verified by DNA sequence analysis.The hVEGF165 gene was subcloned into shuttle vector pAdTrack-CMV.After identified with restriction enzymes,plasmid pAdTrack-hVEGF165 was linearized by digestion with restriction endonuclease PmeⅠ,and subsequently cotransformed into E.coli BJ5183 cells with adenoviral backbone plasmid pAdEasy-1 to make homologous recombination.After linearized by PacⅠ,the homologous recombinant adenovirus plasmid was transfected into HEK293 cells recombinant adenovirus.The high-level adenoviruses infected HEK293 cells and the expression of VEGF-1 by the transfected BMSC was examined with RT-PCR assay and ELISA.Results: The recombinant plasmid pAd-hVEGF165 was subjected to sequence analysis which indicated all nucleotides were identical to the human VEGF165 sequence provided by Genbank.After transfection,the expression of VEGF165 in HEK293 cell was detected.Conclusion: Combinant plasmid pAd-hVEGF165 was constructed in vitro and expressed successfully in HEK293 cells.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2010年第4期430-434,共5页 Medical Journal of Wuhan University
关键词 HVEGF165 基因转染 重组腺病毒 hVEGF165 Gene Transfection Recombinant Adenovirut
  • 相关文献

参考文献8

  • 1Dai J, Rabie ABM. VEGF: an essential mediator of both angiogenesis and endochondral ossification[J]. J Dent Res, 2007,86(10) :937-950.
  • 2Bluteau G, Julien M, Magne D, et al. VEGF and VEGF receptors are differentially expressed in chondrocytes[J]. Bone,2007,40(3) :568-576.
  • 3Dvorak HF, Brown LF, Detmar, et al. Vascular permeability factor vascular endothelial growth factor, microvascular hypermeability, and angiogenesis[J]. Am J Pathol, 1995, 146:1 029-1 039.
  • 4Mayr-Wohlfart U, Waltenberger J, Hausser H, et al Vascular endothelial growth factor stimulates chemo tactic migration of primary human osteoblasts[J].Bone, 2002,30(3) : 472-477.
  • 5Bluteau G, Julien M, Magne D, et al. VEGF and VEGF receptors are differentially expressed in chondrocytes[J]. Bone, 2007,40 (3) :568-576.
  • 6Kanczler JM, Ginty PJ, Barry JJA, et al. The effect of mesenehymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation [J]. Biomaterials, 2008,29 (12):1 892-1 900.
  • 7Li R, Stewart DJ, von Schroeder HP, et al. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect[J]. J Orthop Res,2009,27(1):8-14.
  • 8He TC, Zhou S, Luis T, et al. A simplified system for generating recombinant adenoviruses [J]. Proc Natl Acad Sci USA, 1998, 95(5) :2 509-2 514.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部